References
- Lin P, Mansoor A, Bueso-Ramos C, Hao S, Lai R, Medeiros J L. Diffuse large B-cell lymphoma occurring in patients with lymphoplasmacytic lymphoma/Waldenström macroglobulinemia. Clinicopathologic features of 12 cases. Am J Clin Pathol 2003; 120: 246–253
- Johnson S A. Use of fludarabine in the treatment of mantle cell lymphoma, Waldenstrom's macroglobulinemia and other uncommon B- and T-cell lymphoid malignancies. Hematol J 2004; 5(Suppl 1)S50–S61
- Leblond V, Choquet S. Fludarabine in Waldenstrom's macroglobulinemia. Semin Oncol 2003; 30: 239–242
- Fenchel K, Bergmann L, Wijermans P, Engert A, Pralle H, Mitrou P, et al. Clinical experience with fludarabine and its immunosuppressive effects in pretreated chronic lymphocytic leukemias and low-grade lymphomas. Leuk Lymphoma 1995; 18: 485–492
- Abruzzo L V, Rosales C M, Medeiros L J, Vega F, Luthra R, Manning J T, et al. Epstein-Barr virus-positive B-cell lymphoproliferative disorder arising in immunodeficient patients previously treated with fludarabine for low-grade B-cell neoplasms. Am J Surg Pathol 2002; 26: 630–636
- Lazzarino M, Orlandi E, Balanti F, Furione M, Pagnucco G, Astori C, et al. The immunosuppression and potential for EBV reactivation of fludarabine combined with cyclophosphamide and dexamethasone in patients with lymphoproliferative disorder. Br J Haematol 1999; 107: 877–882
- Van Den Neste E, Delannoy A, Feremans W, Ferrant A, Michaux L. Second primary tumors and immune phenomena after fludarabine or 2-chloro-2′-deoxyadenosine treatment. Leuk Lymphoma 2001; 40: 541–550
- Fazzi R, Caracciolo F, Galimberti S, Petrini M. Early reappearance of primary solid cancer patients treated with purine analogs. J Chemotherapy 2003; 15: 406–408
- Cohen Y, Da'as N, Libster D, Amir G, Berrebi A, Polliack A. Large-cell transformation of chronic lymphocytic leukemia and follicular lymphoma during or soon after treatment with fludarabine-rituximab-containing regimens: natural history- or therapy-related complication?. Eur J Haematol 2002; 68: 80–83
- Svensson A M, Jacobson E R, Ospina D, Tindle B H. Reversible Epstein-Barr virus-negative lymphadenopathy and bone marrow involved by Hodgkin's lymphoma in a rheumatoid arthritis patient undergoing long-term treatment with low-dose methotrexate: a case report and review of the literature. Int J Hematol 2006; 83: 47–50